GlaxoSmithKline Pharmaceuticals Limited Financial Flexibility Index
GlaxoSmithKline Pharmaceuticals Limited financial flexibility index. GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Financial Flexibility Index of 0.02x as of September 2023. Free cash flow of Rs362.20 Million (operating CF Rs362.20 Million minus capex Rs0.00) represents 0% of total liabilities (Rs17.31 Billion). See free cash flow generation of GlaxoSmithKline Pharmaceuticals Limited to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Financial flexibility index of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. Historical Financial Flexibility Index trend for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Check cash flow quality index of GlaxoSmithKline Pharmaceuticals Limited to evaluate the quality of earnings relative to operating cash generation.
GlaxoSmithKline Pharmaceuticals Limited Financial Flexibility Index by Year (2005–2025)
GlaxoSmithKline Pharmaceuticals Limited financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for GlaxoSmithKline Pharmaceuticals Limited. For the full cash flow conversion analysis, see GLAXO cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | Rs13.13 Billion | Rs12.90 Billion | Rs21.57 Billion | ▲ +76.6% |
| 2024 | 0.34x | Rs6.13 Billion | Rs5.82 Billion | Rs17.79 Billion | ▲ +3.4% |
| 2023 | 0.33x | Rs5.28 Billion | Rs4.84 Billion | Rs15.85 Billion | ▼ -22.3% |
| 2022 | 0.43x | Rs8.45 Billion | Rs8.11 Billion | Rs19.70 Billion | ▲ +11.3% |
| 2021 | 0.39x | Rs6.22 Billion | Rs5.78 Billion | Rs16.14 Billion | ▼ -21.6% |
| 2020 | 0.49x | Rs6.46 Billion | Rs4.90 Billion | Rs13.15 Billion | ▲ +26.1% |
| 2019 | 0.39x | Rs6.91 Billion | Rs3.99 Billion | Rs17.71 Billion | ▼ -15.9% |
| 2018 | 0.46x | Rs8.76 Billion | Rs4.73 Billion | Rs18.90 Billion | ▼ -14.5% |
| 2017 | 0.54x | Rs5.40 Billion | Rs2.36 Billion | Rs9.97 Billion | ▲ +97.0% |
| 2016 | 0.28x | Rs3.72 Billion | Rs1.39 Billion | Rs13.50 Billion | ▼ -46.4% |
| 2015 | 0.51x | Rs4.01 Billion | Rs2.70 Billion | Rs7.80 Billion | ▲ +72.3% |
| 2014 | 0.30x | Rs3.40 Billion | Rs2.81 Billion | Rs11.40 Billion | ▼ -8.6% |
| 2013 | 0.33x | Rs3.53 Billion | Rs3.14 Billion | Rs10.82 Billion | ▼ -2.4% |
| 2012 | 0.33x | Rs3.78 Billion | Rs3.36 Billion | Rs11.30 Billion | ▼ -42.7% |
| 2011 | 0.58x | Rs5.01 Billion | Rs4.79 Billion | Rs8.59 Billion | ▼ -23.4% |
| 2010 | 0.76x | Rs5.42 Billion | Rs5.12 Billion | Rs7.12 Billion | ▲ +60.3% |
| 2009 | 0.48x | Rs3.54 Billion | Rs3.30 Billion | Rs7.45 Billion | ▼ -6.8% |
| 2008 | 0.51x | Rs3.34 Billion | Rs3.19 Billion | Rs6.55 Billion | ▲ +7.5% |
| 2007 | 0.47x | Rs2.77 Billion | Rs2.59 Billion | Rs5.84 Billion | ▼ -28.4% |
| 2006 | 0.66x | Rs3.73 Billion | Rs3.49 Billion | Rs5.63 Billion | ▲ +36.2% |
| 2005 | 0.49x | Rs2.38 Billion | Rs2.29 Billion | Rs4.90 Billion | — |